| Acute Adverse Reactions to Gadolinium-Based Contrast Agents in CMR Multicenter Experience With 17,767 Patients From the EuroCMR Registry. | |
| | |
MedLine Citation:
|
PMID: 22093267 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
OBJECTIVES: The purpose of this study was to assess the frequency, manifestation, and severity of acute adverse reactions associated with administration of several gadolinium-based contrast agents to patients who underwent cardiac magnetic resonance (CMR) imaging in the EuroCMR (European Cardiovascular Magnetic Resonance) Registry multinational and multicenter setting. BACKGROUND: The frequency, manifestations, and severity of acute adverse reactions associated with gadolinium-based contrast agents in the specific setting of cardiovascular magnetic resonance have not been systematically evaluated yet. METHODS: This is a multicenter and multinational registry with consecutive enrollment of patients in 45 European centers. During the current observation, 17,767 doses of gadolinium-based contrast agent were administered to 17,767 patients. The mean dose was 25.6 ml (range 5 to 80 ml), which is equivalent to 0.128 mmol/kg (range 0.012 to 0.3 mmol/kg). RESULTS: Thirty acute adverse reactions due to contrast administration occurred (0.17%). All reactions were classified as mild according to the American College of Radiology definition. The most frequent complaints following contrast administration were rashes and hives (9 of 30), followed by nausea (7 of 30), and anxiety (6 of 30). The event rate ranged from 0.06% (linear nonionic agent gadodiamide) to 0.47% (linear ionic agent gadobenate dimeglumine). Interestingly, we also found different event rates between the three main indications for CMR imaging, ranging from 0.1% (risk stratification in suspected coronary artery disease) to 0.42% (viability in known coronary artery disease). CONCLUSIONS: The incidence of acute adverse reactions after administration of gadolinium-based contrast in the "off-label" setting of CMR in our population was not different from the incidence in the U.S. Food and Drug Administration-approved general radiology setting. Thus, the off-label use of gadolinium-based contrast in CMR should be regarded as safe concerning the frequency, manifestation, and severity of acute events. |
| | |
Authors:
|
Oliver Bruder; Steffen Schneider; Detlev Nothnagel; Günter Pilz; Massimo Lombardi; Anil Sinha; Anja Wagner; Thorsten Dill; Herbert Frank; Albert van Rossum; Jürg Schwitter; Eike Nagel; Jochen Senges; Georg Sabin; Udo Sechtem; Heiko Mahrholdt |
Related Documents
:
|
20498437 - Increased diffusivity in acute multiple sclerosis lesions predicts risk of black hole. 15037457 - Diffusion tensor imaging as potential biomarker of white matter injury in diffuse axona... 18044587 - Non-local means variants for denoising of diffusion-weighted and diffusion tensor mri. 21664087 - The effect of a gadolinium-based contrast agent on diffusion tensor imaging. 12664107 - Mri features of bilateral parotid haemangiomas of infancy. 19135927 - Why can we not see a normal appendix on ct? an evaluation of the factors influencing no... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: JACC. Cardiovascular imaging Volume: 4 ISSN: 1876-7591 ISO Abbreviation: JACC Cardiovasc Imaging Publication Date: 2011 Nov |
Date Detail:
|
Created Date: 2011-11-18 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101467978 Medline TA: JACC Cardiovasc Imaging Country: United States |
Other Details:
|
Languages: eng Pagination: 1171-6 Citation Subset: IM |
Copyright Information:
|
Copyright © 2011 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. |
Affiliation:
|
Department of Cardiology and Angiology, Elisabeth Hospital, Essen, Germany. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Flow acceleration time and ratio of acceleration time to ejection time for prosthetic aortic valve f...
Next Document: Pericardial Delayed Hyperenhancement With CMR Imaging in Patients With Constrictive Pericarditis Und...